The summit will serve as a platform to provide networking opportunities for local small businesses and industry leaders in this region.

Amphetamine is bioequivalent to the reference listed drug product (RLD), Adderall XR extended-release capsules of Takeda Pharmaceuticals. T...

"We are pleased to receive approval of Bupropion Hydrochloride (XL) tablet product within first review cycle of 10 months from filing date....

Commenting on the audit, GPI Executive Director Priyanka Chigurupati said, "We are glad to have completed yet another audit with minor obse...

The US Food & Drug Administration (USFDA) granted approval to the abbreviated new drug application (ANDA) filed by Granules Pharmaceuticals...

The drug will be manufactured at the company's manufacturing facility located in Gagillapur, Hyderabad, the filing said.

"We will be responding to the two observations within the stipulated time period," Granules Pharmaceuticals Executive Director Priyanka Chi...

The Hyderabad-based firm plans to invest in a new manufacturing facility and on expanding production capacities at existing plants.

In a BSE filing, Granules said the US Food and Drug Administration (USFDA) has approved the abbreviated new drug application (ANDA) filed b...

Granules has received marketing approval from the US Food and Drug Administration (USFDA) for Potassium Chloride extended release tablets U...

"The US Food and Drug Administration (USFDA) has approved the abbreviated new drug application filed by Granules Pharmaceuticals, Inc, a wh...

Granules India stock was trading at Rs 162.65 apiece, up 2.07 per cent, on the BSE.

The analyst suggested a stoploss at Rs 142.

The investor relations team at Granules India denied the promoters are seeking to sell their stake.